TMEM190

Across TCGA pan-cancer cohorts, TMEM190 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TMEM190 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher TMEM190 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TMEM190 expression acts as an unfavorable survival marker.

LUSC, PRAD, and UCEC are the cancer types where TMEM190 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Median	All	0.239	0.676	.017	18	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TMEM190–LUSC (OS)

Open the LUSC breakdown →